Diabetes Obes Metab 18(2):178185 Tonneijck L, Smits MM, Muskiet MHA, Hoekstra T, Kramer MHH, Danser AHJ et al (2016) Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial
This is the standard onboarding dose, and since your GLP-1 exposure has been relatively low, your provider will likely follow the normal titration from the beginning
As a result of the mounting scientific research linking GLP-1s to gastric illnesses and the tens of thousands adverse reports submitted to the FDA to date, the drug makers now face a growing number of Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits, each raising similar allegations that users were left with painful and debilitating stomach problems, which could have been avoided if false and misleading information had not been provided for users and the medical community
By focusing on quality, bioavailability, and the "Live with Intention" approach, you can move away from the "quick fix" mindset and toward a sustainable wellness journey
These medications may have both positive and negative effects on the gastrointestinal tract
From the copper peptide for skin research that has generated multiple positive human clinical trials, to emerging data on GHK-Cu injection protocols for systemic anti-aging applications, the compound represents a convergence of cosmeceutical, regenerative, and longevity science that is increasingly difficult to ignore
